logo
Plus   Neg
Share
Email

Ventas Boosts FY19 Outlook - Quick Facts

While reporting financial results for the second quarter, Ventas Inc. (VTR) on Friday raised its normalized Funds From Operations (FFO) per share and earnings per share outlook for the full-year 2019.

For fiscal 2019, the company raised its normalized FFO guidance to a range of $3.80 to $3.86 per share from the prior forecast range of $3.75 to $3.85 per share.

The company also now projects earnings per share in a range of $1.38 to $1.45 per share, up from the previous guidance range of $1.23 to $1.38 per share.

On average, analysts polled by Thomson Reuters expect the company to report earnings of $1.29 per share for the year. Analysts' estimates typically exclude special items.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Apple Inc. (AAPL) unveiled a 16-inch MacBook Pro laptop with a larger screen and redesigned keyboard. It is the first major update since the MacBook Pro line was revamped three years ago. The company has moved from a 15-inch screen to a higher-resolution 16-inch screen. Facebook has launched its new payment platform called 'Facebook Pay' in the U.S., joining other tech giants like Google and Apple that have their own payment platforms. The new service will be available across Facebook and its associated apps - Messenger, Instagram and WhatsApp, the social media giant said in a blog post. The payment service supports most major credit and debit cards. Amneal Pharmaceuticals, LLC recalled certain lots of heartburn medication Ranitidine in the form of tablets and syrup for the potential presence of nitrosamine impurity, N-Nitrosodimethylamine, above levels established by the U.S. Food and Drug Administration or FDA. The generic and specialty pharma company is recalling 94 lots of Ranitidine tablets and Syrup.
RELATED NEWS
Follow RTT
>